OR WAIT null SECS
March 02, 2022
Califf will face challenges that include COVID-19, opioids, and user fees.
March 01, 2022
FDA has revised the Emergency Use Authorization for sotrovimab.
AstraZeneca and Neuroimmune have closed an exclusive global collaboration and license agreement to develop and commercialize NI006.
BioMed X and Boehringer Ingelheim have announced the start of a new research project in brain sensor development.
Hovione has announced that Jean-Luc Herbeaux will take over for Guy Villax as CEO on April 1, 2022.
UCB has announced that it is extending its tender offer to acquire Zogenix.
February 28, 2022
EMA has recommended granting a marketing authorization in the EU for Kimmtrak (tebentafusp), a new medicine for a rare type of eye cancer.
EMA has recommended approval of Spikevax for children aged 6 to 11.
Johnson & Johnson has confirmed advancement of the nationwide opioid settlement agreement.
Pfizer and BioNTech receive positive opinion for COVID-19 vaccine booster in adolescents 12 through 17 years of age in the EU.